Skip to content

DR. BIJNENS INGBERT: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

DR. BIJNENS INGBERT

BE 0809.367.307
NACE 86.210, General medical practice
latest balance sheet 30-06-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€553,047 to €684,074

Midpoint €607,642 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €450,958
Capitalised earnings €655,136 to €917,190
Indication €553,047 to €684,074

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€450,958
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€450,958

Capitalised earnings

net result for the year (9904)
2025
€117,757
2024
€54,002
2023
€103,399
2022
€96,942
2021
€125,700
Average result
€91,719
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€655,136 / €764,325 / €917,190

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 30 June 2025. Prepared on 28 September 2026 via checked.be. Indication, not a valuation or advice.